World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
48
Citations
26113
World Ranking
18171
National Ranking
7425

Overview

Adam Bagg is affiliated with the Hospital of the University of Pennsylvania in the United States and has made substantial contributions in the field of medicine, focusing primarily on hematology, pathology, oncology, genetics, and rheumatology.

Their research spans multiple main and subfields, including:

  • Medicine
  • Hematology
  • Pathology and Forensic Medicine
  • Oncology
  • Genetics
  • Rheumatology

The topics covered in their work reflect specialized interests, particularly in the diagnosis and treatment of blood cancers and related disorders:

  • Lymphoma Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Viral-associated cancers and disorders
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Eosinophilic Disorders and Syndromes
  • Cancer Genomics and Diagnostics

Adam Bagg has published numerous papers in several highly regarded scientific venues. Frequent publication venues include:

  • Blood
  • Modern Pathology
  • American Journal of Hematology
  • International Journal of Laboratory Hematology
  • American Journal of Clinical Pathology

Among recent publications authored or co-authored by them are:

  • International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data (2022, Blood)
  • Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia (2022, Blood)
  • Genomic profiling for clinical decision making in lymphoid neoplasms (2022, Blood)
  • Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study (2020, American Journal of Hematology)
  • Evaluation of Scopio Labs X100 Full Field PBS: The first high-resolution full field viewing of peripheral blood specimens combined with artificial intelligence-based morphological analysis (2021, International Journal of Laboratory Hematology)

Frequent collaborators include:

  • Robert P. Hasserjian
  • Daniel A. Arber
  • Attilio Orazi
  • Sa A. Wang
  • Eric D. Hsi

Best Publications

  • Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

    David L. Porter;Bruce L. Levine;Michael Kalos;Adam Bagg

  • T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia

    Michael Kalos;Bruce L. Levine;David L. Porter;Sharyn Katz

  • Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia

    David L. Porter;Wei-Ting Hwang;Noelle V. Frey;Simon F. Lacey

  • Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

    Steven E Raper;Narendra Chirmule;Frank S Lee;Nelson A Wivel

  • Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma

    Gerald P. Linette;Edward A. Stadtmauer;Marcela V. Maus;Aaron P. Rapoport

  • Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma

    Alfred L. Garfall;Marcela V. Maus;Wei-Ting Hwang;Simon F. Lacey

  • International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

    David C. Fajgenbaum;Thomas S. Uldrick;Adam Bagg;Dale Frank

  • Survival of acute myeloid leukemia cells requires PI3 kinase activation

    Qing Xu;Serge Emile Simpson;Timothy J. Scialla;Adam Bagg

  • Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia

    Miriam Y. Kim;Kyung Rok Yu;Saad S. Kenderian;Marco Ruella

  • Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy

    Vijay G. Bhoj;Dimitrios Arhontoulis;Gerald Wertheim;James Capobianchi

  • Erythropoietin gene therapy leads to autoimmune anemia in macaques

    Guangping Gao;Corinna Lebherz;Daniel J. Weiner;Rebecca Grant

  • In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior

    Alejandra Carvajal-Cuenca;Luz F. Sua;Nhora M. Silva;Stefania Pittaluga

  • Guidance for Fluorescence in Situ Hybridization Testing in Hematologic Disorders

    Daynna J. Wolff;Adam Bagg;Linda D. Cooley;Gordon W. Dewald

  • A robust xenotransplantation model for acute myeloid leukemia.

    P V Sanchez;R L Perry;J E Sarry;A E Perl

  • The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder

    Marlise R. Luskin;Daniel S. Heil;Kay S. Tan;Sarah Choi

  • Myeloproliferative Disorders and Myelodysplastic Syndromes

    Jo-Anne Vergilio;Adam Bagg

  • A Phase I Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus and MEC Chemotherapy in Relapsed and Refractory Acute Myelogenous Leukemia

    Alexander E. Perl;Margaret T. Kasner;Donald E. Tsai;Dan T. Vogl

  • Chromosome 3q21 abnormalities associated with hyperactive thrombopoiesis in acute blastic transformation of chronic myeloid leukemia.

    R Bernstein;A Bagg;M Pinto;D Lewis

  • Preexisting Immunity to Adenovirus in Rhesus Monkeys Fails To Prevent Vector-Induced Toxicity

    Andrei N. Varnavski;Yi Zhang;Michael Schnell;John Tazelaar

  • Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.

    Sindhu Cherian;Jonni Moore;Andrew Bantly;Jo Anne Vergilio

Frequent Co-Authors

Martin Carroll
Martin Carroll University of Pennsylvania
David L. Porter
David L. Porter University of Pennsylvania
Carlos E. Bueso-Ramos
Carlos E. Bueso-Ramos The University of Texas MD Anderson Cancer Center
Eric D. Hsi
Eric D. Hsi Cleveland Clinic
Edward A. Stadtmauer
Edward A. Stadtmauer University of Pennsylvania
Carl H. June
Carl H. June University of Pennsylvania
Bruce L. Levine
Bruce L. Levine University of Pennsylvania
Peter C. Nowell
Peter C. Nowell University of Pennsylvania
Michael Kalos
Michael Kalos Next Pillar Consulting
Megan S. Lim
Megan S. Lim University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Biology or Biochemistry opens the door to a wide range of opportunities in healthcare and allied fields. Many students also look at specialized online degrees that provide flexible entry points into the job market. For instance, understanding medical.coding salary trends can help you evaluate if this rapidly growing field aligns with your career goals and earning expectations.

Before pursuing this path, it’s important to weigh both the benefits and drawbacks. Learn more about is medical coding a good career to help you decide if this role fits your interests and skill set. If you prefer broader roles in managing health records or data, look into affordable health information management degree online options, which are increasingly in demand.

Additionally, a master’s in nutrition can complement your background in biochemistry, opening further specialized roles. Discover the cost of masters degree in nutrition programs and find the most budget-friendly paths to advance your education.

Best Scientists Citing Adam Bagg

Trending Scientists

Recently Published Articles